BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9687413)

  • 1. Mode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.
    Ono N; Iwayama S; Suzuki K; Sekiyama T; Nakazawa H; Tsuji T; Okunishi M; Daikoku T; Nishiyama Y
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2095-102. PubMed ID: 9687413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses.
    Lowe DM; Alderton WK; Ellis MR; Parmar V; Miller WH; Roberts GB; Fyfe JA; Gaillard R; Ertl P; Snowden W
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1802-8. PubMed ID: 7486922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiherpesvirus activities of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine (A-5021) in cell culture.
    Iwayama S; Ono N; Ohmura Y; Suzuki K; Aoki M; Nakazawa H; Oikawa M; Kato T; Okunishi M; Nishiyama Y; Yamanishi K
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1666-70. PubMed ID: 9661001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus.
    Earnshaw DL; Bacon TH; Darlison SJ; Edmonds K; Perkins RM; Vere Hodge RA
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2747-57. PubMed ID: 1336346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antiviral activity of novel acyclic nucleosides: discovery of a cyclopropyl nucleoside with potent inhibitory activity against herpesviruses.
    Sekiyama T; Hatsuya S; Tanaka Y; Uchiyama M; Ono N; Iwayama S; Oikawa M; Suzuki K; Okunishi M; Tsuji T
    J Med Chem; 1998 Apr; 41(8):1284-98. PubMed ID: 9548818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
    Sarisky RT; Quail MR; Clark PE; Nguyen TT; Halsey WS; Wittrock RJ; O'Leary Bartus J; Van Horn MM; Sathe GM; Van Horn S; Kelly MD; Bacon TH; Leary JJ
    J Virol; 2001 Feb; 75(4):1761-9. PubMed ID: 11160674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo.
    Neyts J; Andrei G; De Clercq E
    Antimicrob Agents Chemother; 1998 Feb; 42(2):216-22. PubMed ID: 9527762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl]guanine is markedly potentiated by the immunosuppressive agent mycophenolate mofetil.
    Neyts J; De Clercq E
    Antiviral Res; 2001 Feb; 49(2):121-7. PubMed ID: 11248364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]- guanine (A-5021) in mice.
    Iwayama S; Ohmura Y; Suzuki K; Ono N; Nakazawa H; Aoki M; Tanabe I; Sekiyama T; Tsuji T; Okunishi M; Yamanishi K; Nishiyama Y
    Antiviral Res; 1999 Jun; 42(2):139-48. PubMed ID: 10389656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl] x guanine (A-5021) in vitro and in vivo.
    Neyts J; Naesens L; Ying C; De Bolle L; De Clercq E
    Antiviral Res; 2001 Feb; 49(2):115-20. PubMed ID: 11248363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
    Saijo M; Suzutani T; Yoshida I
    Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virus.
    Chono K; Katsumata K; Suzuki H; Shiraki K
    Antiviral Res; 2013 Feb; 97(2):154-60. PubMed ID: 23261844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antiherpesvirus activity of H2G [(R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine] is markedly enhanced by the novel immunosuppressive agent mycophenolate mofetil.
    Neyts J; Andrei G; De Clercq E
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3285-9. PubMed ID: 9835529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antiviral activity of novel anti-VZV 5-substituted uracil nucleosides with a cyclopropane sugar moiety.
    Onishi T; Mukai C; Nakagawa R; Sekiyama T; Aoki M; Suzuki K; Nakazawa H; Ono N; Ohmura Y; Iwayama S; Okunishi M; Tsuji T
    J Med Chem; 2000 Jan; 43(2):278-82. PubMed ID: 10649983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir.
    Standring-Cox R; Bacon TH; Howard BA
    J Virol Methods; 1996 Jan; 56(1):3-11. PubMed ID: 8690764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the Likelihood of Acyclovir Resistance-Associated Mutations in the Thymidine Kinase Genes of Herpes Simplex Virus 1 and Varicella-Zoster Virus.
    Fujii H; Harada S; Yoshikawa T; Yamada S; Omura N; Shibamura M; Inagaki T; Kato H; Fukushi S; Saijo M
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing the sensitivities of noncognate inhibitors to varicella zoster virus thymidine kinase: implications for postherpetic neuralgia therapy with existing agents.
    Yang L; Mo X; Yang H; Dai H; Tan F
    J Mol Model; 2014 Jul; 20(7):2321. PubMed ID: 24961898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of varicella-zoster virus-induced DNA polymerase by a new guanosine analog, 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine triphosphate.
    Abele G; Eriksson B; Harmenberg J; Wahren B
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1137-42. PubMed ID: 2847643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor.
    Yajima M; Yamada H; Takemoto M; Daikoku T; Yoshida Y; Long T; Okuda T; Shiraki K
    Antiviral Res; 2017 Mar; 139():95-101. PubMed ID: 28027917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir.
    Suzutani T; Ishioka K; De Clercq E; Ishibashi K; Kaneko H; Kira T; Hashimoto K; Ogasawara M; Ohtani K; Wakamiya N; Saijo M
    Antimicrob Agents Chemother; 2003 May; 47(5):1707-13. PubMed ID: 12709344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.